Volume 32, No 8, Aug 2022

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 32 Issue 8, August 2022: 789-789   |  Open Access

CORRIGENDA

Author Correction: Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue

Fan Yang^1,† , Huanhuan Zhang^1,† , Xianyu Meng^1,† , Yingge Li¹ , Yingxin Zhou¹ , Shenglong Ling¹ , Demeng Sun¹ , Pei Lv¹ , Lei Liu^2,* , Pan Shi^1,* , Changlin Tian^1,3,*

¹The First Affiliated Hospital of USTC, School of Life Sciences, Division of Life Sciences and Medicine, Joint Center for Biological Analytical Chemistry, Anhui Engineering Laboratory of Peptide Drug, Anhui Laboratory of Advanced Photonic Science and Technology, University of Science and Technology of China, Hefei, Anhui, China
²TsinghuaPeking Joint Center for Life Sciences, Ministry of Education Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Department of Chemistry, Tsinghua University, Beijing, China
³High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, Anhui, China
^†These authors contributed equally: Fan Yang, Huanhuan Zhang, Xianyu Meng
Correspondence: Lei Liu(lliu@mail.tsinghua.edu.cn)Pan Shi(shipan@ustc.edu.cn)Changlin Tian(cltian@ustc.edu.cn)

Correction to: Cell Research https://doi.org/10.1038/s41422-022-00646-6, published online 29 March 2022

https://doi.org/10.1038/s41422-022-00667-1

FULL TEXT | PDF

Browse 662